It is not recommended to use simultaneously with eye drops containing metal ions (silver solutions, collargol, zinc sulfate), because Clarvisan changes color in their presence.
Coated tablets
It is possible to develop superficial keratitis, blepharitis, redness of the conjunctiva, a burning sensation or itching after instilling the drug.
The initial stages of senile cataracts.
Pyrenoxine competitively inhibits the action of quinone substances produced as a result of abnormal metabolism of aromatic amino acids and stimulating the conversion of water-soluble protein in the lens to insoluble, resulting in the substance of the lens becomes cloudy. By inhibiting the action inanovich substances, pirenoxine prevents the development of cataracts.
Clarvisan
Pirenoxine
Conjunctivally. Immediately before use, dissolve 1 tablet in 15 ml of solvent and instill in the conjunctival sac 1-2 drops of the solution 3-5 times a day.
